{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:01:45Z","timestamp":1790841705173,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11033-022-07700-x","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T20:02:40Z","timestamp":1656273760000},"page":"10715-10727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["SARS-CoV-2 cell entry beyond the ACE2 receptor"],"prefix":"10.1007","volume":"49","author":[{"given":"Shamila D.","family":"Alipoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5298-8442","authenticated-orcid":false,"given":"Mehdi","family":"Mirsaeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,26]]},"reference":[{"key":"7700_CR1","unstructured":"World Health Organization, Corona virus disease (COVID-19) pandemic. Available at https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019, 2022."},{"issue":"10224","key":"7700_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565\u2013574","journal-title":"Lancet"},{"issue":"7798","key":"7700_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F et al (2020) A new coronavirus associated with human respiratory disease in China. Nature 579(7798):265\u2013269","journal-title":"Nature"},{"key":"7700_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.563085","author":"SD Alipoor","year":"2021","unstructured":"Alipoor SD et al (2021) COVID-19: molecular and cellular response. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2021.563085","journal-title":"Front Cell Infect Microbiol"},{"key":"7700_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P et al (2020) The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 76:14\u201320","journal-title":"Eur J Intern Med"},{"issue":"2","key":"7700_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou X et al (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14(2):185\u2013192","journal-title":"Front Med"},{"key":"7700_CR7","doi-asserted-by":"publisher","first-page":"105254","DOI":"10.1016\/j.meegid.2022.105254","volume":"99","author":"N Kirtipal","year":"2022","unstructured":"Kirtipal N et al (2022) Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage. Infect, Genet Evolut 99:105254","journal-title":"Infect, Genet Evolut"},{"issue":"1","key":"7700_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"F Qi","year":"2020","unstructured":"Qi F et al (2020) Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun 526(1):135\u2013140","journal-title":"Biochem Biophys Res Commun"},{"key":"7700_CR9","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.csbj.2021.03.025","volume":"19","author":"A Jobe","year":"2021","unstructured":"Jobe A, Vijayan R (2021) Neuropilins: C-end rule peptides and their association with nociception and COVID-19. Comput Struct Biotechnol J 19:1889\u20131895","journal-title":"Comput Struct Biotechnol J"},{"key":"7700_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","volume":"6","author":"F Scialo","year":"2020","unstructured":"Scialo F et al (2020) ACE2: the major cell entry receptor for SARS-CoV-2. Lung 6:867\u2013877","journal-title":"Lung"},{"issue":"7","key":"7700_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","volume":"43","author":"H Kai","year":"2020","unstructured":"Kai H, Kai M (2020) Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors\u2014lessons from available evidence and insights into COVID-19. Hypertens Res 43(7):648\u2013654","journal-title":"Hypertens Res"},{"issue":"20","key":"7700_CR12","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek TG et al (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348(20):1953\u20131966","journal-title":"N Engl J Med"},{"issue":"6965","key":"7700_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450\u2013454","journal-title":"Nature"},{"issue":"2","key":"7700_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280.e8","journal-title":"Cell"},{"issue":"2","key":"7700_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC et al (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181(2):281-292.e6","journal-title":"Cell"},{"issue":"1","key":"7700_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11357-020-00300-2","volume":"43","author":"M Fagyas","year":"2021","unstructured":"Fagyas M et al (2021) Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19. Geroscience 43(1):19\u201329","journal-title":"Geroscience"},{"issue":"7047","key":"7700_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y et al (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112\u2013116","journal-title":"Nature"},{"issue":"26","key":"7700_CR18","doi-asserted-by":"publisher","first-page":"18056","DOI":"10.1074\/jbc.M802694200","volume":"283","author":"X-L Yu","year":"2008","unstructured":"Yu X-L et al (2008) Crystal structure of HAb18G\/CD147: implications for immunoglobulin superfamily homophilic adhesion. J Biol Chem 283(26):18056\u201318065","journal-title":"J Biol Chem"},{"issue":"3","key":"7700_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-2249.2010.04115.x","volume":"160","author":"V Yurchenko","year":"2010","unstructured":"Yurchenko V et al (2010) Cyclophilin\u2013CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol 160(3):305\u2013317","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"7700_CR20","doi-asserted-by":"publisher","first-page":"6360","DOI":"10.1073\/pnas.111583198","volume":"98","author":"T Pushkarsky","year":"2001","unstructured":"Pushkarsky T et al (2001) CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci USA 98(11):6360\u20136365","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"7700_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1086\/427811","volume":"191","author":"Z Chen","year":"2005","unstructured":"Chen Z et al (2005) Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis 191(5):755\u2013760","journal-title":"J Infect Dis"},{"issue":"3","key":"7700_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.32794\/mr11250069","volume":"3","author":"D Loh","year":"2020","unstructured":"Loh D (2020) The potential of melatonin in the prevention and attenuation of oxidative hemolysis and myocardial injury from cd147 SARS-CoV-2 spike protein receptor binding. Melatonin Res 3(3):380\u2013416","journal-title":"Melatonin Res"},{"issue":"7527","key":"7700_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature13715","volume":"515","author":"KE Wright","year":"2014","unstructured":"Wright KE et al (2014) Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature 515(7527):427\u2013430","journal-title":"Nature"},{"key":"7700_CR24","first-page":"1","volume":"16","author":"MA Helal","year":"2020","unstructured":"Helal MA et al (2020) Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia. J Biomol Struct Dyn 16:1\u201311","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"7700_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang K et al (2020) CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 5(1):1\u201310","journal-title":"Signal Transduct Target Ther"},{"key":"7700_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0159-1","author":"QW Li Tan","year":"2020","unstructured":"Li Tan QW et al (2020) Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-020-0159-1","journal-title":"Signal Transduct Target Ther"},{"key":"7700_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.virusres.2014.02.010","volume":"184","author":"J Carbajo-Lozoya","year":"2014","unstructured":"Carbajo-Lozoya J et al (2014) Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including alisporivir. Virus Res 184:44\u201353","journal-title":"Virus Res"},{"issue":"3","key":"7700_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbrc.2004.07.003","volume":"321","author":"C Luo","year":"2004","unstructured":"Luo C et al (2004) Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun 321(3):557\u2013565","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7700_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1385\/IR:21:2-3:211","volume":"21","author":"A Saphire","year":"2000","unstructured":"Saphire A, Bobardt MD, Gallay PA (2000) Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells. Immunol Res 21(2):211\u2013217","journal-title":"Immunol Res"},{"issue":"6","key":"7700_CR30","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/cells10061434","volume":"10","author":"C Fenizia","year":"2021","unstructured":"Fenizia C et al (2021) SARS-CoV-2 entry: at the crossroads of CD147 and ACE2. Cells 10(6):1434","journal-title":"Cells"},{"issue":"4","key":"7700_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1189\/jlb.3RU1116-477R","volume":"101","author":"FU Dawar","year":"2017","unstructured":"Dawar FU et al (2017) Updates in understanding the role of cyclophilin A in leukocyte chemotaxis. J Leukoc Biol 101(4):823\u2013826","journal-title":"J Leukoc Biol"},{"key":"7700_CR32","first-page":"747","volume-title":"Seminars in thrombosis and hemostasis","author":"GJ Pennings","year":"2014","unstructured":"Pennings GJ et al (2014) CD147 in cardiovascular disease and thrombosis. Seminars in thrombosis and hemostasis. Thieme Medical Publishers, New York, pp 747\u2013755"},{"key":"7700_CR33","doi-asserted-by":"publisher","unstructured":"Cao M et al (2019) Role of CyPA in cardiac hypertrophy and remodeling. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20193190","DOI":"10.1042\/BSR20193190"},{"key":"7700_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.virol.2015.08.010","volume":"485","author":"JL Nieto-Torres","year":"2015","unstructured":"Nieto-Torres JL et al (2015) Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 485:330\u2013339","journal-title":"Virology"},{"issue":"23","key":"7700_CR35","first-page":"11992","volume":"24","author":"H Faghihi","year":"2020","unstructured":"Faghihi H (2020) CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2. Eur Rev Med Pharmacol Sci 24(23):11992\u201311994","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"7700_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80464-1","volume":"11","author":"J Shilts","year":"2021","unstructured":"Shilts J et al (2021) No evidence for basigin\/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep 11(1):1\u201310","journal-title":"Sci Rep"},{"issue":"49","key":"7700_CR37","doi-asserted-by":"publisher","first-page":"29120","DOI":"10.1074\/jbc.R115.687327","volume":"290","author":"HF Guo","year":"2015","unstructured":"Guo HF et al (2015) Neuropilin function as an essential cell surface receptor. J Biol Chem 290(49):29120\u201329126","journal-title":"J Biol Chem"},{"key":"7700_CR38","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3389\/fimmu.2017.01228","volume":"8","author":"S Roy","year":"2017","unstructured":"Roy S et al (2017) Multifaceted role of neuropilins in the immune system: potential targets for immunotherapy. Front Immunol 8:1228","journal-title":"Front Immunol"},{"key":"7700_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.697079","author":"SD Alipoor","year":"2021","unstructured":"Alipoor SD et al (2021) The immunopathogenesis of neuroinvasive lesions of SARS-CoV-2 infection in COVID-19 patients. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.697079","journal-title":"Front Neurol"},{"issue":"1","key":"7700_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ygeno.2004.02.001","volume":"84","author":"FC Cackowski","year":"2004","unstructured":"Cackowski FC et al (2004) Shi-Yuan Cheng, identification of two alternatively spliced neuropilin-1 isoforms. Genomics 84(1):82\u201394","journal-title":"Genomics"},{"issue":"1","key":"7700_CR41","first-page":"1","volume":"6","author":"H-B Wang","year":"2015","unstructured":"Wang H-B et al (2015) Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells. Nat Commun 6(1):1\u201313","journal-title":"Nat Commun"},{"issue":"8","key":"7700_CR42","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/aps.2017.17","volume":"38","author":"L-L Zhang","year":"2017","unstructured":"Zhang L-L et al (2017) Human T-cell lymphotropic virus type 1 and its oncogenesis. Acta Pharmacol Sin 38(8):1093\u20131103","journal-title":"Acta Pharmacol Sin"},{"issue":"38","key":"7700_CR43","doi-asserted-by":"publisher","first-page":"16157","DOI":"10.1073\/pnas.0908201106","volume":"106","author":"T Teesalu","year":"2009","unstructured":"Teesalu T et al (2009) C-end rule peptides mediate neurophilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA 106(38):16157\u201316162","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6518","key":"7700_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370(6518):861\u2013865","journal-title":"Science"},{"issue":"6518","key":"7700_CR45","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518):856\u2013860","journal-title":"Science"},{"issue":"1","key":"7700_CR46","doi-asserted-by":"publisher","first-page":"e1009153","DOI":"10.1371\/journal.ppat.1009153","volume":"17","author":"BS Mayi","year":"2021","unstructured":"Mayi BS et al (2021) The role of Neuropilin-1 in COVID-19. PLoS Pathog 17(1):e1009153","journal-title":"PLoS Pathog"},{"issue":"5","key":"7700_CR47","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.apsb.2018.06.006","volume":"8","author":"R Wang","year":"2018","unstructured":"Wang R et al (2018) Efficacy of inverso isomer of CendR peptide on tumor tissue penetration. Acta Pharm Sin B 8(5):825\u2013832","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"7700_CR48","first-page":"4221","volume":"22","author":"J Davies","year":"2020","unstructured":"Davies J et al (2020) Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep 22(5):4221\u20134226","journal-title":"Mol Med Rep"},{"issue":"8","key":"7700_CR49","doi-asserted-by":"publisher","first-page":"e1002896","DOI":"10.1371\/journal.pgen.1002896","volume":"8","author":"NK Hanchate","year":"2012","unstructured":"Hanchate NK et al (2012) SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with kallmann syndrome. PLoS Genet 8(8):e1002896","journal-title":"PLoS Genet"},{"issue":"6","key":"7700_CR50","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jinf.2020.08.029","volume":"81","author":"E Garrigues","year":"2020","unstructured":"Garrigues E et al (2020) Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 81(6):e4\u2013e6","journal-title":"J Infect"},{"issue":"4","key":"7700_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/0167-5699(94)90316-6","volume":"15","author":"B Fleischer","year":"1994","unstructured":"Fleischer B (1994) CD26: a surface protease involved in T-cell activation. Immunol Today 15(4):180\u2013184","journal-title":"Immunol Today"},{"issue":"1","key":"7700_CR52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA (2020) Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 9(1):601\u2013604","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"7700_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","volume":"16","author":"Q Wang","year":"2014","unstructured":"Wang Q et al (2014) Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16(3):328\u2013337","journal-title":"Cell Host Microbe"},{"issue":"13","key":"7700_CR54","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.3390\/ijms22137001","volume":"22","author":"K Cameron","year":"2021","unstructured":"Cameron K, Rozano L, Falasca M, Mancera RL (2021) Does the SARSCoV-2 spike protein receptor binding domain interact effectively with the DPP4 (CD26) receptor? a molecular docking study. Int J Mol Sci 22(13):7001","journal-title":"Int J Mol Sci"},{"issue":"6","key":"7700_CR55","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","volume":"17","author":"W Tai","year":"2020","unstructured":"Tai W et al (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 17(6):613\u2013620","journal-title":"Cell Mol Immunol"},{"key":"7700_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00080","author":"CF Deacon","year":"2019","unstructured":"Deacon CF (2019) Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2019.00080","journal-title":"Front Endocrinol"},{"key":"7700_CR57","doi-asserted-by":"publisher","first-page":"108125","DOI":"10.1016\/j.diabres.2020.108125","volume":"162","author":"G Iacobellis","year":"2020","unstructured":"Iacobellis G (2020) COVID-19 and diabetes: can DPP4 inhibition play a role? Diabetes Res Clin Pract 162:108125","journal-title":"Diabetes Res Clin Pract"},{"key":"7700_CR58","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fimmu.2015.00386","volume":"6","author":"D R\u00f6hrborn","year":"2015","unstructured":"R\u00f6hrborn D, Wronkowitz N, Eckel J (2015) DPP4 in diabetes. Front Immunol 6:386","journal-title":"Front Immunol"},{"issue":"4","key":"7700_CR59","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1109\/TCBB.2020.3009099","volume":"18","author":"C Cui","year":"2021","unstructured":"Cui C et al (2021) AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells. IEEE\/ACM Trans Comput Biol Bioinf 18(4):1230\u20131233","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"issue":"11","key":"7700_CR60","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3390\/app10114053","volume":"10","author":"I Cosic","year":"2020","unstructured":"Cosic I, Cosic D, Loncarevic I (2020) RRM prediction of erythrocyte Band3 protein as alternative receptor for SARS-CoV-2 virus. Appl Sci 10(11):4053","journal-title":"Appl Sci"},{"issue":"3","key":"7700_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MOH.0000000000000418","volume":"25","author":"YM Abbas","year":"2018","unstructured":"Abbas YM et al (2018) Band 3 function and dysfunction in a structural context. Curr Opin Hematol 25(3):163\u2013170","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"7700_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/membranes7040056","volume":"7","author":"T Aoki","year":"2017","unstructured":"Aoki T (2017) A comprehensive review of our current understanding of red blood cell (RBC) glycoproteins. Membranes 7(4):56","journal-title":"Membranes"},{"issue":"6","key":"7700_CR63","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1128\/jvi.66.6.3409-3414.1992","volume":"66","author":"N Miller","year":"1992","unstructured":"Miller N, Hutt-Fletcher LM (1992) Epstein-barr virus enters B cells and epithelial cells by different routes. J Virol 66(6):3409\u20133414","journal-title":"J Virol"},{"issue":"3","key":"7700_CR64","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0092-8674(02)00628-1","volume":"108","author":"SM Akula","year":"2002","unstructured":"Akula SM et al (2002) Integrin \u03b13\u03b21 (CD 49c\/29) is a cellular receptor for Kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV-8) entry into the target cells. Cell 108(3):407\u2013419","journal-title":"Cell"},{"issue":"11","key":"7700_CR65","first-page":"2669","volume":"160","author":"HA Hussein","year":"2015","unstructured":"Hussein HA et al (2015) Beyond RGD: virus interactions with integrins. Adv Virol 160(11):2669\u20132681","journal-title":"Adv Virol"},{"key":"7700_CR66","doi-asserted-by":"publisher","first-page":"104759","DOI":"10.1016\/j.antiviral.2020.104759","volume":"177","author":"CJ Sigrist","year":"2020","unstructured":"Sigrist CJ, Bridge A, Le Mercier P (2020) A potential role for integrins in host cell entry by SARS-CoV-2. Antivir Res 177:104759","journal-title":"Antivir Res"},{"issue":"1","key":"7700_CR67","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1083\/jcb.127.1.257","volume":"127","author":"TJ Wickham","year":"1994","unstructured":"Wickham TJ et al (1994) Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 127(1):257\u2013264","journal-title":"J Cell Biol"},{"issue":"43","key":"7700_CR68","doi-asserted-by":"publisher","first-page":"15470","DOI":"10.1073\/pnas.0406821101","volume":"101","author":"AL Feire","year":"2004","unstructured":"Feire AL, Koss H, Compton T (2004) Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci USA 101(43):15470\u201315475","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"7700_CR69","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1073\/pnas.0308368101","volume":"101","author":"NJ Philpott","year":"2004","unstructured":"Philpott NJ et al (2004) Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-\u03b1 induction pathway. Proc Natl Acad Sci USA 101(16):6200\u20136205","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"7700_CR70","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41422-021-00595-6","volume":"32","author":"Y Gu","year":"2022","unstructured":"Gu Y et al (2022) Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res 32(1):24\u201337","journal-title":"Cell Res"},{"issue":"5","key":"7700_CR71","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.chom.2018.03.019","volume":"23","author":"J Staring","year":"2018","unstructured":"Staring J et al (2018) KREMEN1 is a host entry receptor for a major group of enteroviruses. Cell host microbe 23(5):636-643.e5","journal-title":"Cell host microbe"},{"issue":"12","key":"7700_CR72","doi-asserted-by":"publisher","first-page":"e52190","DOI":"10.1371\/journal.pone.0052190","volume":"7","author":"SK Mishra","year":"2012","unstructured":"Mishra SK et al (2012) High-affinity Dkk1 receptor kremen1 is internalized by clathrin-mediated endocytosis. PLoS ONE 7(12):e52190","journal-title":"PLoS ONE"},{"issue":"1","key":"7700_CR73","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/JVI.77.1.546-559.2003","volume":"77","author":"B Saunier","year":"2003","unstructured":"Saunier B et al (2003) Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol 77(1):546\u2013559","journal-title":"J Virol"},{"issue":"6377","key":"7700_CR74","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/357420a0","volume":"357","author":"CL Yeager","year":"1992","unstructured":"Yeager CL et al (1992) Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357(6377):420\u2013422","journal-title":"Nature"},{"issue":"8","key":"7700_CR75","doi-asserted-by":"publisher","first-page":"e1002859","DOI":"10.1371\/journal.ppat.1002859","volume":"8","author":"J Reguera","year":"2012","unstructured":"Reguera J et al (2012) Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathog 8(8):e1002859","journal-title":"PLoS Pathog"},{"key":"7700_CR76","doi-asserted-by":"publisher","DOI":"10.4172\/2153-0602.1000211","author":"RS Holmes","year":"2017","unstructured":"Holmes RS et al (2017) Aminopeptidase genes (ENPEP) and proteins: comparative studies of a major contributor to arterial hypertension. J Data Min Genomics Proteomics. https:\/\/doi.org\/10.4172\/2153-0602.1000211","journal-title":"J Data Min Genomics Proteomics"},{"issue":"4","key":"7700_CR77","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11427-021-1990-5","volume":"65","author":"S Zhu","year":"2022","unstructured":"Zhu S et al (2022) Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry. Sci China Life Sci 65(4):701\u2013717","journal-title":"Sci China Life Sci"},{"issue":"6458","key":"7700_CR78","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1126\/science.aay3353","volume":"365","author":"M Hiraizumi","year":"2019","unstructured":"Hiraizumi M et al (2019) Cryo-EM structures capture the transport cycle of the P4-ATPase flippase. Science 365(6458):1149\u20131155","journal-title":"Science"},{"issue":"8","key":"7700_CR79","doi-asserted-by":"publisher","first-page":"e0200988","DOI":"10.1371\/journal.pone.0200988","volume":"13","author":"N Takasugi","year":"2018","unstructured":"Takasugi N et al (2018) TMEM30A is a candidate interacting partner for the \u03b2-carboxyl-terminal fragment of amyloid-\u03b2 precursor protein in endosomes. PLoS ONE 13(8):e0200988","journal-title":"PLoS ONE"},{"issue":"7837","key":"7700_CR80","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41586-020-2915-3","volume":"588","author":"H Ma","year":"2020","unstructured":"Ma H et al (2020) LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. Nature 588(7837):308\u2013314","journal-title":"Nature"},{"key":"7700_CR81","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1016\/j.csbj.2021.06.041","volume":"19","author":"CA Beaudoin","year":"2021","unstructured":"Beaudoin CA et al (2021) Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses. Comput Struct Biotechnol J 19:3938\u20133953","journal-title":"Comput Struct Biotechnol J"},{"key":"7700_CR82","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"IT Hamming","year":"2004","unstructured":"Hamming IT et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637","journal-title":"J Pathol"},{"key":"7700_CR83","first-page":"87","volume-title":"Hepatitis C virus","author":"MB Zeisel","year":"2013","unstructured":"Zeisel MB, Felmlee DJ, Baumert TF (2013) Hepatitis C virus entry. Hepatitis C virus. Springer, Berlin, pp 87\u2013112"},{"key":"7700_CR84","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.jmb.2018.03.034","volume":"430","author":"A Helenius","year":"2018","unstructured":"Helenius A (2018) Virus entry: looking back and moving forward. J Mol Biol 430:1853\u20131862","journal-title":"J Mol Biol"},{"issue":"12","key":"7700_CR85","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/glycob\/cwaa042","volume":"30","author":"A Shajahan","year":"2020","unstructured":"Shajahan A et al (2020) Deducing the N-and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Glycobiology 30(12):981\u2013988","journal-title":"Glycobiology"},{"key":"7700_CR86","doi-asserted-by":"publisher","first-page":"110368","DOI":"10.1016\/j.mehy.2020.110368","volume":"146","author":"L Pruimboom","year":"2021","unstructured":"Pruimboom L (2021) SARS-CoV 2; possible alternative virus receptors and pathophysiological determinants. Med Hypotheses 146:110368","journal-title":"Med Hypotheses"},{"issue":"17","key":"7700_CR87","doi-asserted-by":"publisher","first-page":"9131","DOI":"10.3390\/ijms22179131","volume":"22","author":"V Kumar","year":"2021","unstructured":"Kumar V, Singh J, Hasnain SE, Sundar D (2021) Possible link between higher transmissibility of alpha, kappa and delta variants of SARSCoV-2 and increased structural stability of its spike protein and hACE2 affinity. Int J Mol Sci 22(17):9131","journal-title":"Int J Mol Sci"},{"issue":"6575","key":"7700_CR88","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.abl8506","volume":"374","author":"M McCallum","year":"2021","unstructured":"McCallum M et al (2021) Molecular basis of immune evasion by the delta and kappa SARSCoV-2 variants. Science 374(6575):1621\u20131626","journal-title":"Science"},{"issue":"1","key":"7700_CR89","doi-asserted-by":"publisher","first-page":"103589","DOI":"10.1016\/j.isci.2021.103589","volume":"25","author":"B Lubinski","year":"2022","unstructured":"Lubinski B et al (2022) Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B. 1.1. 7 (Alpha) spike. Iscience 25(1):103589","journal-title":"Iscience"},{"issue":"3","key":"7700_CR90","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41577-022-00681-9","volume":"22","author":"L Pia","year":"2022","unstructured":"Pia L, Rowland-Jones S (2022) Omicron entry route. Nat Rev Immunol 22(3):144\u2013144","journal-title":"Nat Rev Immunol"},{"key":"7700_CR91","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova P et al (2021) SARS-CoV-2 B. 1.617. 2 delta variant replication and immune evasion. Nature 599:114\u2013119","journal-title":"Nature"},{"issue":"1","key":"7700_CR92","first-page":"96","volume":"17","author":"S Kumar","year":"2021","unstructured":"Kumar S et al (2021) Omicron and delta variant of SARS-CoV-2: a comparative computational study of spike protein. J Med Virol 17(1):96","journal-title":"J Med Virol"},{"issue":"4","key":"7700_CR93","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb RL et al (2022) Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med 386(4):305\u2013315","journal-title":"N Engl J Med"},{"issue":"6575","key":"7700_CR94","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen DR et al (2021) An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science 374(6575):1586\u20131593","journal-title":"Science"},{"issue":"6","key":"7700_CR95","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal A et al (2022) Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med 386(6):509\u2013520","journal-title":"N Engl J Med"},{"issue":"3","key":"7700_CR96","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.hjc.2020.10.008","volume":"62","author":"F Triposkiadis","year":"2020","unstructured":"Triposkiadis F et al (2020) Fallacies in medical practice: renin-angiotensin-aldosterone system inhibition and COVID-19 as a paradigm. Hell J Cardiol 62(3):185\u2013189","journal-title":"Hell J Cardiol"},{"issue":"11","key":"7700_CR97","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","volume":"8","author":"A Zoufaly","year":"2020","unstructured":"Zoufaly A et al (2020) Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med 8(11):1154\u20131158","journal-title":"Lancet Respir Med"},{"issue":"2","key":"7700_CR98","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-079X.1999.tb00602.x","volume":"27","author":"L Tesoriere","year":"1999","unstructured":"Tesoriere L et al (1999) Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity. J Pineal Res 27(2):95\u2013105","journal-title":"J Pineal Res"},{"key":"7700_CR99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/117739280700200017","volume":"2","author":"K Watashi","year":"2007","unstructured":"Watashi K, Shimotohno K (2007) Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target. Drug target insights 2:9\u201318","journal-title":"Drug target insights"},{"issue":"5","key":"7700_CR100","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1021\/jm901755g","volume":"53","author":"A Jarvis","year":"2010","unstructured":"Jarvis A et al (2010) Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. J Med Chem 53(5):2215\u20132226","journal-title":"J Med Chem"},{"issue":"49","key":"7700_CR101","doi-asserted-by":"publisher","first-page":"29120","DOI":"10.1074\/jbc.R115.687327","volume":"290","author":"H-F Guo","year":"2015","unstructured":"Guo H-F, Craig W, Kooi V (2015) Neuropilin functions as an essential cell surface receptor. J Biol Chem 290(49):29120\u201329126","journal-title":"J Biol Chem"},{"issue":"5","key":"7700_CR102","doi-asserted-by":"publisher","first-page":"L834","DOI":"10.1152\/ajplung.00031.2018","volume":"315","author":"T Kawasaki","year":"2018","unstructured":"Kawasaki T et al (2018) DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 315(5):L834\u2013L845","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"7700_CR103","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.41058","volume":"72","author":"A Soare","year":"2020","unstructured":"Soare A et al (2020) Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis. Arthr Rheumatol 72(1):137\u2013149","journal-title":"Arthr Rheumatol"},{"issue":"24","key":"7700_CR104","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1128\/JVI.02448-13","volume":"87","author":"K Ohnuma","year":"2013","unstructured":"Ohnuma K et al (2013) Inhibition of middle east respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody. J Virol 87(24):13892\u201313899","journal-title":"J Virol"},{"issue":"4","key":"7700_CR105","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ddr.21641","volume":"81","author":"D Conole","year":"2020","unstructured":"Conole D et al (2020) Discovery of a novel fluorescent chemical probe suitable for evaluation of neuropilin-1 binding of small molecules. Drug Dev Res 81(4):491\u2013500","journal-title":"Drug Dev Res"},{"key":"7700_CR106","unstructured":"Sciences, S.B.U.o.M. Azithromycin in Hospitalized COVID-19 Patients. 2020; Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04359316."}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07700-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T12:37:34Z","timestamp":1667133454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07700-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,26]]},"references-count":106,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7700"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07700-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,26]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None for both authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}